D

Denali Therapeutics
D

DNLI

13.950
USD
-0.13
(-0.92%)
Market Open
Volume
21,704
EPS
-3
Div Yield
-
P/E
-5
Market Cap
2,026,604,371
OverviewSignalsIdeasNews
Related Instruments
A
ABEO
-0.08000
(-1.33%)
5.93000 USD
A
ARWR
-0.280
(-1.79%)
15.340 USD
C
CRSP
-0.050
(-0.11%)
44.380 USD
E
EDIT
-0.10000
(-4.26%)
2.24500 USD
F
FATE
-0.02500
(-2.08%)
1.17500 USD
N
NTLA
-0.37500
(-3.91%)
9.22500 USD
R
RGNX
-0.05000
(-0.58%)
8.50000 USD
S
SGMO
-0.01250
(-2.58%)
0.47150 USD
V
VYGR
-0.06500
(-2.14%)
2.97000 USD
More
News
BYD Sets New Sales Record Amidst China’s EV Market Slowdown

BYD Sets New Sales Record Amidst China’s EV Market Slowdown

9 months ago
Stocks News
Treasury Yields Decline as Market Anticipates Fed Rate Cuts

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

9 months ago
Economy News
Novo Nordisk Surges in Profit and Sales

Novo Nordisk Surges in Profit and Sales

1 year ago
Stocks News
Xiaomi's Stock Surges After it Releases its First EV

Xiaomi's Stock Surges After it Releases its First EV

1 year ago
Stocks News
More

Title: Denali Therapeutics

Sector: Healthcare
Industry: Biotechnology
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brainpenetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.